The Division of Infectious Diseases and HIV Medicine is expanding our translational research program, and investigating cutting-edge technologies, vaccines, and therapeutic treatments for the management and prevention of HIV and other infectious diseases. Current and pending research studies involve close collaborations with the College of Medicine's Department of Microbiology and Immunology, and Department of Emergency Medicine, as well as the Dornsife School of Public Health at Drexel University.
Dr. El Haddad conducts research in several areas within the field of infectious diseases and HIV. Active grants include:
- "Immune Responses in the Elderly to Vaccination and Infection"
- "Boosting anti-HIV immunity through manipulation of Tfh function"
- "Preservation of adaptive immunity leads to HIV control upon treatment cessation"
- BAA-NIHAI2013168, Adjuvant Discovery Program
- "Persistent modulation of microbiota to enhance HIV vaccination"
Learn more about the Haddad Lab
Michele Kutzler, PhD, is currently investigating the development of DNA vaccines, therapeutics to treat Clostridium difficile, and the immune responses of intravenous drug users. In addition, her lab processes specimens from the Division's clinical research studies.
Visit the Kutzler Lab
Drexel's new Division of Infectious Diseases Clinical Research Center (CRC) is located on the 3rd floor at 1427 Vine Street in Philadelphia, one floor above the Partnership Comprehensive Care Practice. Our clinical research team guides patients through all stages of the research process and provides expert coordination of health care services for all of our participants. Our clinical research team has also contributed significantly to prior and ongoing clinical trials evaluating strategies for eradication and functional cure of HIV infection through therapeutic vaccination approaches and the use of novel anti-HIV agents.
Division of Infectious Disease Clinical Research Center
1427 Vine Street, 3rd floor
Philadelphia, PA 19102
Phone: 267.507.6647 (Research Department)
Back to Top